The Medical-Surgical Dermatology and Venereology Department at the Clínica Universidad de Navarra has vast experience in diagnosis and treatment of dermatological diseases.
We have wide experience in extremely precise surgical treatments, such as Mohs surgery . This procedure can only be carried out by highly specialised professionals.
Equally, the Clínica has extensive experience in the surgical treatment of specific types of skin cancer.
We have the latest technology for dermaesthetic treatment of skin lesions, aiming to obtain the best results for our patients: Neodimio-Yag Q-Switched laser, PDL laser (Pulsed Dye Laser), long pulse Neodimio-Yag laser, CO2 laser, long pulse Alexandrite laser, digital dermatoscope and the latest photodynamic therapy.
We also work together, along with other departments at the Clínica, in different units and areas that treat a wide range of pathologies for a multidisciplinary care approach.
The main diagnostic method we use in Dermatology is a direct examination of the lesions. Occasionally, the dermatologist needs to take samples of the lesion for analysis and to confirm the diagnosis.
When a disease is suspected of being infectious, it is useful for the specialist to take a culture from the area for microbiological analysis.
Digital Dermatoscopy is a painless diagnostic procedure that involves recording high quality images of each mole or supposed lesion, so that the specialists can examine them more deeply.
This technique is very precise and useful in the early diagnosis of an eventual malignancy. This makes it possible for patients to undergo a more simple and efficient surgical treatment. This test is carried out when the patient has a suspicious dermatological lesion. Furthermore, it´s especially recommended for patients who are prone to develop moles or have a high number of them on their skin. Also, those with personal or family history of melanoma, require regular examination. Finally, it is very useful for controlling any atypical moles in patients with very few moles.
El objetivo del ensayo es evaluar si el medicamento del ensayo, tralokinumab, es mejor que el placebo o «tratamiento simulado» para tratar la dermatitis atópica grave (un tipo de eczema) en personas que no pueden tratarse con ciclosporina A. Esto se determinará mediante diferentes pruebas que evalúan la gravedad y el alcance de la dermatitis atópica, el picor y otros síntomas, así como el estado general de salud y la calidad de vida. Los participantes en el ensayo recibirán tralokinumab o placebo, además de corticoides tópicos (crema con esteroides), que ya pueden estar usando para tratar su dermatitis atópica.
Actas Dermo-sifiliográficas Mar 11, 201
The treatment is unique. That gentleness of the nurses and the entire personnel remains the same and is much appreciated".
Julia de la R.
Patient who was operated on for a leg melanoma